mFOLFOX6 Clinical Trials
8 recruitingDrug
Phase 24Phase 34Phase 12
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast CancerEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more
Boehringer Ingelheim768 enrolled108 locationsNCT06324357
Recruiting
Phase 2
Total Neoadjuvant Therapy in Rectal Cancer
Rectal Cancer
National Cheng-Kung University Hospital42 enrolled1 locationNCT06162650
Recruiting
Phase 3
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang166 enrolled1 locationNCT06791512
Recruiting
Phase 3
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Dominik Paul Modest507 enrolled79 locationsNCT05008809
Recruiting
Phase 2
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
Sun Yat-sen University143 enrolled1 locationNCT05571644
Recruiting
Phase 1Phase 2
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Zhejiang Cancer Hospital90 enrolled1 locationNCT06650332
Recruiting
Phase 3
A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis
Metastatic Colorectal Cancer
Yuhong Li142 enrolled1 locationNCT02102789
Recruiting
Phase 3
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Patients With Resected Stage II Colon Cancer
Centre Hospitalier Universitaire Dijon1,980 enrolled1 locationNCT04120701